UBS O'Connor’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9K | Sell |
30,000
-18,865
| -39% | -$13.2K | ﹤0.01% | 264 |
|
|
2025
Q1 | $53.3K | Sell |
48,865
-155,714
| -76% | -$170K | ﹤0.01% | 235 |
|
|
2024
Q4 | $205K | Buy |
204,579
+96,894
| +90% | +$96.9K | 0.01% | 308 |
|
|
2024
Q3 | $178K | Sell |
107,685
-10,000
| -8% | -$16.5K | ﹤0.01% | 367 |
|
|
2024
Q2 | $131K | Sell |
117,685
-50,000
| -30% | -$55.5K | ﹤0.01% | 395 |
|
|
2024
Q1 | $221K | Sell |
167,685
-432,549
| -72% | -$571K | 0.01% | 369 |
|
|
2023
Q4 | $900K | Sell |
600,234
-161,453
| -21% | -$242K | 0.03% | 276 |
|
|
2023
Q3 | $1.12M | Sell |
761,687
-30,000
| -4% | -$44.1K | 0.02% | 313 |
|
|
2023
Q2 | $1.99M | Buy |
791,687
+105,555
| +15% | +$265K | 0.04% | 292 |
|
|
2023
Q1 | $1.02M | Buy |
+686,132
| New | +$1.02M | 0.02% | 394 |
|
|
2022
Q4 | – | Sell |
-197,988
| Closed | -$626K | – | 151 |
|
|
2022
Q3 | $626K | Sell |
197,988
-34,603
| -15% | -$109K | 0.01% | 776 |
|
|
2022
Q2 | $807K | Buy |
+232,591
| New | +$807K | 0.01% | 773 |
|
|
2017
Q3 | – | Sell |
-4,700
| Closed | -$545K | – | 358 |
|
|
2017
Q2 | $545K | Sell |
4,700
-300
| -6% | -$34.8K | 0.01% | 329 |
|
|
2017
Q1 | $800K | Buy |
+5,000
| New | +$800K | 0.01% | 342 |
|
|
2015
Q2 | – | Sell |
-375
| Closed | -$375K | – | 780 |
|
|
2015
Q1 | $375K | Buy |
375
+125
| +50% | +$125K | 0.01% | 562 |
|
|
2014
Q4 | $249K | Buy |
+250
| New | +$249K | ﹤0.01% | 574 |
|